Table 23-5.

Time Trends in GWTG-Stroke Quality-of-Care Measures, 2006 to 2014

Quality-of-Care Measure200620072008200920102011201220132014
IV tPA in patients who arrived ≤2 h after symptom onset, treated ≤3 h*56.060.564.473.976.278.382.083.386.4
IV tPA in patients who arrived <3.5 h after symptom onset, treated ≤4.5 h42.557.960.464.372.3
IV tPA door-to-needle time ≤60 min22.524.925.928.029.533.839.959.366.2
Antithrombotic agents <48 h after admission*94.995.896.096.196.396.796.997.097.2
DVT prophylaxis by second hospital day*85.488.992.292.792.293.598.498.398.7
Antithrombotic agents at discharge*94.195.197.097.897.798.197.897.698.0
Anticoagulation for atrial fibrillation at discharge*88.289.593.193.593.593.193.493.694.8
Therapy at discharge if LDL-C >100 mg/dL or LDL-C not measured or on therapy at time of admission*61.667.573.488.189.089.894.595.996.9
Counseling for smoking cessation*86.192.194.396.396.797.096.896.396.5
Composite quality-of-care measure83.186.189.794.794.294.496.396.496.9
  • Values are percentages. DVT indicates deep vein thrombosis; GWTG, Get With The Guidelines; IV, intravenous; LDL-C, low-density lipoprotein cholesterol; and tPA, tissue-type plasminogen activator.

  • * Indicates the 7 key achievement measures targeted in GWTG-Stroke.